Topics

Astellas continues to make deals, partnering with Adaptimmune

04:59 EST 15 Jan 2020 | BioPharma-Reporter

The newly established deal includes the co-development of up to three T-cell therapies, by utilizing the latterâs stem-cell derived allogeneic T-cell platform.

Original Article: Astellas continues to make deals, partnering with Adaptimmune

NEXT ARTICLE

More From BioPortfolio on "Astellas continues to make deals, partnering with Adaptimmune"

Quick Search